Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05283226
Title Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NATCO Pharma Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Providence Medical Foundation -Fullerton RECRUITING Fullerton California 92835 United States Details
Los Angeles Hematology Oncology Medical Group COMPLETED Los Angeles California 90017 United States Details
Lynn Cancer Center RECRUITING Boca Raton Florida 33486 United States Details
Miami Cancer Center RECRUITING Miami Florida 33176 United States Details
Norton Cancer Institute - Downtown RECRUITING Louisville Kentucky 40202 United States Details
University of Maryland Greenebaum Cancer Center RECRUITING Baltimore Maryland 21201-1544 United States Details
Washington University - Siteman Cancer Center RECRUITING Saint Louis Missouri 63110 United States Details
Salib Oncology RECRUITING Easton Pennsylvania 18045 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
Daycare Angels under AOH RECRUITING Mumbai Maharashtra 40001 India Details
Grant Medical Foundation Ruby Hall Clinic RECRUITING Pune Maharashtra 411001 India Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field